Statement Of Investigator (FDA Form 1572) In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica FDA's Overreach on Compounded Peptides